Skip to main content

Advertisement

Log in

Cytochrome c oxidase deficit is associated with the seizure onset zone in young patients with focal cortical dysplasia Type II

  • Research Article
  • Published:
Metabolic Brain Disease Aims and scope Submit manuscript

Abstract

It has been postulated that mitochondrial dysfunction may be an important factor in epileptogenesis of intractable epilepsy. The current study tests the hypothesis that mitochondrial Complex IV (CIV) or cytochrome c oxidase dysfunction is associated with the seizure onset zone (SOZ) in patients with focal cortical dysplasia (FCD). Subjects were selected based on: age <19y; epilepsy surgery between May, 2010 and October, 2011; pathological diagnosis of isolated focal cortical dysplasia Type I (FCDI) or Type II (FCDII); and sufficient residual cortical tissue to conduct analysis of electron transport chain complex (ETC) activity in SOZ and adjacent cortical regions. In this retrospective study, patients were identified who had sufficient unfixed, frozen brain tissue for biochemical analysis in tissue homogenates. Specimens were subtyped using ILAE classification for FCD, and excluded if diagnosed with FCD Type III or dual pathology. Analysis of ETC activity in resected tissues was conducted independently and without knowledge of the identity, diagnosis, or clinical status of individual subjects. Seventeen patients met the inclusion criteria, including 6 FCDI and 11 FCDII. Comparison of adjacent cortical resections showed decreased CIV activity in the SOZ of the FCDII group (P = 0.003), but no significant CIV difference in adjacent tissues of the FCDI group. Because of the importance of CIV as the terminal and rate-limiting complex in the mitochondrial electron transport chain, these authors conclude that 1) a deficit of CIV is associated with the SOZ of patients with FCDII; 2) CIV deficiency may contribute to the spectrum of FCD neuropathology; and 3) further investigation of CIV in FCD may lead to the discovery of new targets for neuroprotective therapies for patients with intractable epilepsy.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

Abbreviations

CIII:

decylubiquinol-cytochrome c oxidoreductase

CIV:

cytochrome c oxidase

CS:

citrate synthase

ICEEG:

intracranial electrocorticography

ETC:

electron transport chain

FCD:

focal cortical dysplasia

FDG-PET:

2-[18 F]fluoro-2-deoxy-D-glucose positron emission tomography

MRI:

magnetic resonance imaging

NCP:

non-collagen protein

SOZ:

seizure onset zone

SSZ:

secondary spread zone

SDH:

succinate dehydrogenase

References

  • Abdijadid S, Mathern GW, Levine MS, Cepeda C (2015) Basic mechanisms of epileptogenesis in pediatric cortical dysplasia. CNS Neurosci Ther 21:92–103

  • Aguiar CC, Almeida AB, Araújo PV, de Abreu RN, Chaves EM, do Vale OC et al (2012) Oxidative stress and epilepsy: literature review. Oxid Med Cell Longev 2012:795259

    Article  PubMed Central  PubMed  Google Scholar 

  • Arnold S (2012) The power of life-COX takes center stage in metabolic control, cell signaling and survival. Mitochondrion 12:46–56

    Article  CAS  PubMed  Google Scholar 

  • Aronica E, Becker AJ, Spreafico R (2012) Malformations of cortical development. Brain Pathol 22:380–401

    Article  PubMed  Google Scholar 

  • Asano E, Brown EC, Juhász C (2013) How to establish causality in epilepsy surgery. Brain Dev 35:706–720

    Article  PubMed Central  PubMed  Google Scholar 

  • Bae YS, Kang HC, Kim HD, Kim SH (2012) New classification of focal cortical dysplasia: application to practical diagnosis. J Epilepsy Res 2:38–42

    Article  PubMed Central  PubMed  Google Scholar 

  • Blümcke I, Thom M, Aronica E, Armstrong DD, Vinters HV, Palmini A et al (2011) The clinicopathologic spectrum of focal cortical dysplasias: a consensus classification proposed by an ad hoc Task Force of the ILAE Diagnostic Methods Commission. Epilepsia 52:158–174

    Article  PubMed Central  PubMed  Google Scholar 

  • Böhm M, Pronicka E, Karczmarewicz E, Pronicki M, Piekutowska-Abramczuk D, Sykut-Cegielska J et al (2006) Retrospective, multicentric study of 180 children with cytochrome c oxidase deficiency. Pediatr Res 59:21–26

  • Bourens M, Fontanesi F, Soto IC, Liu J, Barrientos A (2012) Redox and reactive oxygen species regulation of mitochondrial COX biogenesis. Antioxid Redox Signal 19:1940–1952

    Article  PubMed  Google Scholar 

  • Cepeda C, André VM, Vinters HV, Levine MS, Mathern GW (2005) Are cytomegalic neurons and balloon cells generators of epileptic activity in pediatric cortical dysplasia? Epilepsia 46(Suppl 5):82–88

    Article  PubMed  Google Scholar 

  • Chamberlain WA, Cohen ML, Gyure KA, Kleinschmidt-DeMasters BK, Perry A, Powell SZ et al (2009) Interobserver and intraobserver reproducibility in focal cortical dysplasia (malformations of cortical development). Epilepsia 50:2593–2598

    Article  PubMed  Google Scholar 

  • Chen SD, Chang AY, Chuang YC (2010) The potential role of mitochondrial dysfunction in seizure-associated cell death in the hippocampus and epileptogenesis. J Bioenerg Biomembr 42:461–465

    Article  CAS  PubMed  Google Scholar 

  • Coras R, de Boer OJ, Armstrong D, Becker A, Jacques TS, Miyata H et al (2012) Good interobserver and intraobserver agreement in the evaluation of the new ILAE classification of focal cortical dysplasias. Epilepsia 53:1341–1348

    Article  PubMed  Google Scholar 

  • Fauser S, Essang C, Altenmüller DM, Staack A, Steinhoff BJ, Strobl K et al (2013) Is there evidence for clinical differences related to the new classification of temporal lobe cortical dysplasia? Epilepsia 54:909–917

    Article  PubMed  Google Scholar 

  • Folbergrová J, Kunz WS (2012) Mitochondrial dysfunction in epilepsy. Mitochondrion 12:35–40

    Article  PubMed  Google Scholar 

  • Fujiwara H, Greiner HM, Lee KH, Holland-Bouley KD, Seo JH, Arthur T et al (2012) Resection of ictal high-frequency oscillations leads to favorable surgical outcome in pediatric epilepsy. Epilepsia 53:1607–1617

    Article  PubMed Central  PubMed  Google Scholar 

  • Gao J, Yao H, Pan XD, Xie AM, Zhang L, Song JH et al (2014) Alteration of mitochondrial function and ultrastructure in the hippocampus of pilocarpine-treated rat. Epilepsy Res 108:162–170

    Article  CAS  PubMed  Google Scholar 

  • Hauptman JS, Mathern GW (2012) Surgical treatment of epilepsy associated with cortical dysplasia: 2012 update. Epilepsia 53(Suppl 4):98–104

    Article  PubMed  Google Scholar 

  • Hoppel CL, Kerr DS, Dahms B, Roessmann U (1987) Deficiency of the reduced nicotinamide adenine dinucleotide dehydrogenase component of complex I of mitochondrial electron transport. J Clin Invest 80:71–77

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  • Iyer A, Zurolo E, Spliet WG, van Rijen PC, Baayen JC, Gorter JA, Aronica E (2010) Evaluation of the innate and adaptive immunity in Type I and Type II focal cortical dysplasias. Epilepsia 51:1763–1773

    Article  CAS  PubMed  Google Scholar 

  • Kang HC, Lee YM, Kim HD (2013) Mitochondrial disease and epilepsy. Brain Dev 35:757–761

    Article  PubMed  Google Scholar 

  • Khurana DS, Valencia I, Goldenthal MJ, Legido A (2013) Mitochondrial dysfunction in epilepsy. Semin Pediatr Neurol 20:176–187

    Article  PubMed  Google Scholar 

  • Krahenbuhl S, Chang M, Brass EP, Hoppel CL (1991) Decreased activities of ubiquinol: FerriCytochrome C oxidoreductase (complex III) and ferroCytochrome C; oxygen oxidoreductase (complex IV) in liver mitochondria from rats with hydroxycobalamin[c-lactam]-induced methylmalonic aciduria. J Biol Chem 266:20998–21003

    CAS  PubMed  Google Scholar 

  • Krsek P, Pieper T, Karlmeier A, Hildebrandt M, Kolodziejczyk D, Winkler P et al (2009) Different presurgical characteristics and seizure outcomes in children with focal cortical dysplasia Type I or II. Epilepsia 50:125–137

    Article  PubMed  Google Scholar 

  • Larsen S, Nielsen J, Hansen CN, Nielsen LB, Wibrand F, Stride N et al (2012) Biomarkers of mitochondrial content in skeletal muscle of healthy young human subjects. J Physiol 590(Pt 14):3349–3360

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  • Leach JL, Miles L, Henkel DM, Greiner HM, Kukreja MK, Holland KD et al (2014) Magnetic resonance imaging abnormalities in the resection region correlate with histopathological type, gliosis extent, and postoperative outcome in pediatric cortical dysplasia. J Neurosurg Pediatr 14:68–80

    Article  PubMed  Google Scholar 

  • Lerner JT, Salamon N, Hauptman JS, Velasco TR, Hemb M, Wu JY et al (2009) Assessment and surgical outcomes for mild Type I and severe Type II cortical dysplasia: a critical review and the UCLA experience. Epilepsia 50:1310–1335

    Article  PubMed  Google Scholar 

  • Lilienthal JL Jr, Zierler KL, Folk BP, Buka R, Riley MJ (1950) A reference base and system for analysis of muscle constituents. J Biol Chem 182:501–508

    CAS  Google Scholar 

  • Lim KC, Crino PB (2013) Focal malformations of cortical development: new vistas for molecular pathogenesis. Neuroscience 252:262–76

  • Liu J, Reeves C, Michalak Z, Coppola A, Diehl B, Sisodiya SM, Thom M (2014) Evidence for mTOR pathway activation in a spectrum of epilepsy-associated pathologies. Acta Neuropathol Commun 2:71

    Article  PubMed Central  PubMed  Google Scholar 

  • Lüders HO, Najm I, Nair D, Widdess-Walsh P, Bingman W (2006) The epileptogenic zone: general principles. Epileptic Disord 8(Suppl 2):S1–9

    PubMed  Google Scholar 

  • Lukasiuk K, Becker AJ (2014) Molecular biomarkers of epileptogenesis. Neurotherapeutics 11:319–323

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  • Martinc B, Grabnar I, Vovk T (2012) The role of reactive species in epileptogenesis and influence of antiepileptic drug therapy on oxidative stress. Curr Neuropharmacol 10:328–343

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  • Milatovic D, Zivin M, Gupta RC, Dettbarn WD (2001) Alterations in cytochrome c oxidase activity and energy metabolites in response to kainic acid-induced status epilepticus. Brain Res 912:67–78

  • Miles L, Greiner HM, Miles MV, Mangano FT, Horn PS, Leach JL et al (2013) Interaction between Akt1-positive neurons and age at surgery is associated with surgical outcome in children with isolated focal cortical dysplasia. J Neuropathol Exp Neurol 72:884–891

    Article  PubMed  Google Scholar 

  • Mühlebner A, Coras R, Kobow K, Feucht M, Czech T, Stefan H et al (2012) Neuropathologic measurements in focal cortical dysplasias: validation of the ILAE 2011 classification system and diagnostic implications for MRI. Acta Neuropathol 123:259–272

    Article  PubMed  Google Scholar 

  • Otáhal J, Suchomelová L, Druga R, Kubová H (2005) Changes in cytochrome oxidase in the piriform cortex after status epilepticus in adult rats. Epilepsia 46(Suppl 5):89–93

    Article  PubMed  Google Scholar 

  • Otáhal J, Folbergrová J, Kovacs R, Kunz WS, Maggio N (2014) Epileptic focus and alteration of metabolism. Int Rev Neurobiol 114:209–243

    Article  PubMed  Google Scholar 

  • Otsubo H, Iida K, Oishi M, Okuda C, Ochi A, Pang E et al (2005) Neurophysiologic findings of neuronal migration disorders: intrinsic epileptogenicity of focal cortical dysplasia on electroencephalography, electrocorticography, and magnetoencephalography. J Child Neurol 20:357–63

    Article  PubMed  Google Scholar 

  • Pickrell AM, Fukui H, Wang X, Pinto M, Moraes CT (2011) The striatum is highly susceptible to mitochondrial oxidative phosphorylation dysfunctions. J Neurosci 31:9895–9904

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  • Rodenburg RJ (2011) Biochemical diagnosis of mitochondrial disorders. J Inherit Metab Dis 34:283–292

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  • Rowley S, Patel M (2013) Mitochondrial involvement and oxidative stress in temporal lobe epilepsy. Free Radic Biol Med 62:121–131

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  • Rustin P, Chretien D, Bourgeron T, Gérard B, Rötig A, Saudubray JM, Munnich A (1994) Biochemical and molecular investigations in respiratory chain deficiencies. Clin Chim Acta 228:35–51

    Article  CAS  PubMed  Google Scholar 

  • Sarnat HB, Flores-Sarnat L, Hader W, Bello-Espinosa L (2011) Mitochondrial “hypermetabolic” neurons in paediatric epileptic foci. Can J Neurol Sci 38:909–917

    Article  PubMed  Google Scholar 

  • Seo JH, Holland K, Rose D, Rozhkov L, Fujiwara H, Byars A et al (2011) Multimodality imaging in the surgical treatment of children with nonlesional epilepsy. Neurology 76:41–48

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  • Sisodiya SM, Fauser S, Cross JH, Thom M (2009) Focal cortical dysplasia Type II: biological features and clinical perspectives. Lancet Neurol 8:830–843

    Article  PubMed  Google Scholar 

  • Srere PA (1969) Citrate synthase. Methods Enzymol 13:3–11

    Article  CAS  Google Scholar 

  • Srinivasan S, Avadhani NG (2012) Cytochrome c oxidase dysfunction in oxidative stress. Free Radic Biol Med 53:1252–1263

  • Thorburn DR, Chow CW, Kirby DM (2004) Respiratory chain enzyme analysis in muscle and liver. Mitochondrion 4:363–375

    Article  CAS  PubMed  Google Scholar 

  • Vielhaber S, Von Oertzen JH, Kudin AF, Schoenfeld A, Menzel C, Biersack HJ et al (2003) Correlation of hippocampal glucose oxidation capacity and interictal FDG-PET in temporal lobe epilepsy. Epilepsia 44:193–199

    Article  CAS  PubMed  Google Scholar 

  • Wiedemann FR, Vielhaber S, Schröder R, Elger CE, Kunz WS (2000) Evaluation of methods for the determination of mitochondrial respiratory chain enzyme activities in human skeletal muscle samples. Anal Biochem 279:55–60

    Article  CAS  PubMed  Google Scholar 

  • Wong-Riley MT (1989) Cytochrome oxidase: an endogenous metabolic marker for neuronal activity. Trends Neurosci 12:94–101

    Article  CAS  PubMed  Google Scholar 

  • Wong-Riley MT (2012) Bigenomic regulation of cytochrome c oxidase in neurons and the tight coupling between neuronal activity and energy metabolism. Adv Exp Med Biol 748:283–304

  • Yuen AW, Sander JW (2011) Impaired mitochondrial energy production: the basis of pharmacoresistance in epilepsy. Med Hypotheses 77:536–540

    Article  CAS  PubMed  Google Scholar 

  • Zhang J, Liu W, Chen H, Xia H, Zhou Z, Mei S et al (2013) Multimodal neuroimaging in presurgical evaluation of drug-resistant epilepsy. Neuroimage Clin 4:35–44

    Article  PubMed Central  PubMed  Google Scholar 

Download references

Ethical approval

All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards. For this type of study formal consent is not required.

Conflict of interest

The authors declare that they have no conflict of interest.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Lili Miles.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Miles, L., Greiner, H.M., Mangano, F.T. et al. Cytochrome c oxidase deficit is associated with the seizure onset zone in young patients with focal cortical dysplasia Type II. Metab Brain Dis 30, 1151–1160 (2015). https://doi.org/10.1007/s11011-015-9680-2

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11011-015-9680-2

Keywords

Navigation